Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 64-69 , March 2008

Association of beta-blocker use with increased aortic wave reflection

Received 27 August 2007 ,Accepted 11 October 2007.

References 

  1. Lindholm LH, Carlberg B, Samuelsson O. Should β-blockers remain first choice in the treatment of primary hypertension? (A meta-analysis). Lancet. 2005;366:1545–1553
  2. Bradley HA, Wiysonge CS, Volmink JA, Mayosi BM, Opie LH. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? (Systematic review and meta-analysis). J Hypertens. 2006;24:2131–2141
  3. Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. BMJ. 2003;326:681
  4. Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE) Study. J Hypertens. 2003;21:1563–1574
  5. Messerli FH. The LIFE study: the straw that should break the camel’s back. Eur Heart J. 2003;24:487–489
  6. Cruickshank JM, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens. 1992;6:85–90
  7. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17:118–123
  8. Chen C, Ting C, Lin S, Hsu T, Yin F, Siu C, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension. 1995;25:1034–1041
  9. Hirata K, Vlachopoulos C, Adji A, O’Rourke MF. Benefits from angiotensin-converting enzyme inhibitor beyond blood pressure lowering: beyond the blood pressure or beyond the brachial artery?. J Hypertens. 2005;23:551–556
  10. Polonia J, Barbosa L, Silva JA, Maldonado J. Different influences on central and peripheral pulse pressure, aortic wave reflections and pulse wave velocity of three different types of antihypertensive drugs. Rev Port Cardiol. 2000;22:1485–1492
  11. Dhakam Z, McEniery CM, Yasmin , Cockcroft JR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens. 2006;19:214–219
  12. Asmar RG, London GM, O’Rourke ME, Safar ME REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness, and wave reflections with a very low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension. 2001;38:922–926
  13. Davies J, Carr E, Band M, Morris A, Struthers A. Do losartan and atenolol have differential effects on BNP and central hemodynamic parameters?. J Renin Angiotensin Aldosterone Syst. 2005;6:151–153
  14. De Cessaris R, Ranieri G, Filitti V, Andriani A. Large artery compliance in essential hypertension: effects of calcium antagonism and beta-blocking. Am J Hypertens. 1992;5:624–628
  15. Savolainen A, Keto P, Poutanen VP, Hekali P, Standertskjold-Nordenstam CG, Rames A, et al. Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension. J Cardiovasc Pharmacol. 1996;27:99–104
  16. Rohani M, Jogestrand T, Margareta Ekberg M, van der Linden J, Källner G, Jussila R, et al. Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease. Atherosclerosis. 2005;179:311–316
  17. Chen C, Nevo E, Fetics B, Pak PH, Yin FCP, Maughan WL, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation. 1997;95:1827–1836
  18. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525:263–270
  19. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15
  20. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–1117
  21. Vyas M, Izzo JL, Lacourciere Y, Arnold JM, Dunlap ME, Amato JL, et al. Augmentation index and central aortic stiffness in middle-aged to elderly individuals. Am J Hypertens. 2007;20:642–647
  22. Sugawara J, Komine H, Hayashi K, Maeda S, Matsuda M. Relationship between augmentation index obtained from carotid and radial artery pressure waveforms. J Hypertens. 2007;25:375–381
  23. The CAFÉ Investigators, for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators. Differential impact of blood-lowering drugs on central aortic pressure and clinical outcomes (Principal results of the Conduit Artery Function Evaluation (CAFÉ) Study). Circulation. 2006;13:1213–1225
  24. Cameron JD, McGrath BP, Dart AM. Use of radial artery applanation tonometry and a generalized transfer function to determine aortic pulse pressure augmentation in subjects with treated hypertension. J Am Coll Cardiol. 1998;32:1214–1220
  25. Wong ND, Thakral G, Franklin SS, L’Italian GJ, Jacobs MJ, Whyte JL, et al. Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am Heart J. 2003;145:888–895
  26. Nishino M, Masugata H, Yamada Y, Abe H, Hori M, Kamada T. Evaluation of thoracic aortic atherosclerosis by transesophageal echocardiography. Am Heart J. 1994;127:336–344
  27. Toyoda K, Yasaka M, Nagata S, Yamaguchi T. Aortogenic embolic stroke: a transesophageal echocardiographic approach. Stroke. 1992;23:1056–1061
  28. Fazio GP, Redberg RF, Winslow T, Schiller NB. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol. 1993;21:144–150
  29. Tribouilloy C, Shen WF, Peltier M, Lesbre JP. Noninvasive prediction of coronary artery disease by transesophageal echocardiographic detection of thoracic aortic plaque in valvular heart disease. Am J Cardiol. 1994;74:258–260
  30. Joshi N, Athanasopoulos G, Oakley CM. Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol. 1993;71:1208–1212

 Conflict of interest: none.

PII: S1933-1711(07)00206-9

doi: 10.1016/j.jash.2007.10.007

Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 64-69 , March 2008

Article Tools

* Image Usage & Resolution